San Clemente, CA – March 6, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary…
Read More
Global PAD Assn. Recognizes Reflow Medical CEO Isa Rizk John Phillips, MD talks about raising PAD awareness with the winner of the “Corporate Champion of Awareness” Award, our own Isa…
On November 5, 2024, the VIVA Foundation reported on presentations at the VIVA25 conference, including two-year results of the DEEPER OUS clinical trial for the Reflow Medical Spur® Peripheral Retrievable…
Updates on Spur® Retrievable Scaffold Therapy (RST) at AMP At the Amputation Prevention Symposium (AMP) held in Chicago in August, S. Jay Mathews, MD, provided an excellent review: “Retrievable Stent…
Enrollment Completed in the DEEPER REVEAL Clinical Trial We want to thank everyone who worked to complete enrollment in the DEEPER REVEAL clinical trial (NCT05358353) to evaluate Spur™ Retrievable Scaffold…
San Clemente, CA – July 1, 2024 – Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in “A pilot study of…
San Clemente, CA – May 08, 2024 – Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces completion of enrollment in the DEEPER REVEAL clinical trial…
CE Mark Certification for the Bare Temporary Spur Stent System Reflow has received CE (Conformité Européenne) Mark certification in the European Union for the Bare Temporary Spur Stent System for…
San Clemente, CA—Jan. 15, 2024 – Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the…
SAN CLEMENTE, CA — November 6, 2023 — Reflow Medical announced one-year results of the DEEPER OUS clinical trial (NCT04162418) evaluating the company’s Bare Temporary Spur Stent System. Results were…
Recent Comments